ArticleUlcerative colitis: Responding to the challengesAuthor:Jean-Paul Achkar, MD Publish date: September 1, 2007Aminosalicylates are the first-line therapy for patients with mild to moderate active ulcerative colitis. Infliximab is now approved for moderately... Read More
